SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-013940
Filing Date
2020-11-17
Accepted
2020-11-17 17:03:36
Documents
12
Period of Report
2020-11-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20201117x8k.htm   iXBRL 8-K 38691
  Complete submission text file 0001558370-20-013940.txt   159355

Data Files

Seq Description Document Type Size
2 EX-101.SCH krbp-20201117.xsd EX-101.SCH 2982
3 EX-101.LAB krbp-20201117_lab.xml EX-101.LAB 16071
4 EX-101.PRE krbp-20201117_pre.xml EX-101.PRE 10261
5 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20201117x8k_htm.xml XML 4904
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 201321903
SIC: 2836 Biological Products, (No Diagnostic Substances)